ET
CAI

Entropy Technologies’s Caris Life Sciences CAI Stock Holding History

Entropy Technologies’s Portfolio CAI Stock Details CAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$479K Sell
26,887
-13,616
-34% -$244K 0.02% 674
2026
Q1 		$724K Buy
+40,503
New +$885K 0.03% 495

Other funds holding CAI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JHWEPV
J. H. Whitney Equity Partners VI New Canaan, Connecticut $201M AUM
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
SSP
Sixth Street Partners Dallas, Texas $579M AUM 2.46% 1-Year Est. Return
PC
PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Entropy Technologies's CAI Position: Q2 2026 in Review

Entropy Technologies reduced its Caris Life Sciences (CAI) stake by 34% in Q2 2026, selling an estimated $244K and leaving 26,887 shares worth $479K. The position accounts for 0.02% of the portfolio, ranked #674.

Entropy Technologies first reported a position in CAI in Q1 2026 and has held it in 2 quarters since. The position peaked at $724K in Q1 2026. 246 funds tracked by Wall St. Rank hold CAI as of Q2 2026.

  • Entropy Technologies held 26,887 shares of Caris Life Sciences worth $479K as of Q2 2026.
  • Entropy Technologies sold 13,616 Caris Life Sciences shares in Q2 2026, an estimated $244K.
  • Caris Life Sciences made up 0.02% of Entropy Technologies's portfolio in Q2 2026, its #674 holding.
  • Entropy Technologies first reported a position in Caris Life Sciences in Q1 2026 and has held it in 2 quarters since.
  • Entropy Technologies's Caris Life Sciences position peaked at $724K in Q1 2026.
  • 246 funds tracked by Wall St. Rank held Caris Life Sciences as of Q2 2026.

Based on Entropy Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.